Market Overview

Cancer Genetics (NASDAQ: CGIX)

0.29 -0.02 (-7.29%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2019
After-Hours
EPS:
REV:
-0.31
5.94M



Q2 2019
Pre-Market
EPS:
REV:
-0.13
7.036M



Q1 2019
Pre-Market
EPS:
REV:
-0.16
7.667M



Q4 2018
After-Hours
EPS:
REV:
-0.36
7.523M



Q3 2018
After-Hours
EPS:
REV:
-0.16
8.028M

7.57M
-0.31
5.94M

-21.53%
Q2 2018
Pre-Market
EPS:
REV:
-0.16
6.604M
-0.16
8.3M
-0.13
7.036M
-18.75%
-15.23%
Q1 2018
Pre-Market
EPS:
REV:
-0.11
6.966M
-0.13
8.2M
-0.16
7.667M
23.08%
-6.5%
Q4 2017
After-Hours
EPS:
REV:
-0.15
7.23M
-0.11
9.19M
-0.36
7.523M
227.27%
-18.14%
Q3 2017
Pre-Market
EPS:
REV:
-0.23
6.75M
-0.12
8.07M
-0.16
8.028M
33.33%
-0.52%
Q2 2017
After-Hours
EPS:
REV:
-0.28
7.001M
-0.15
7.97M
-0.16
6.604M
6.67%
-17.14%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!